Table 5. Univariate and multivariate analysis of recurrence free survival for 530 invasive breast cancer patients.
Univariate | Multivariate | |||
---|---|---|---|---|
Factors | HR(95% CI) | P value | HR (95% CI) | P value |
Age | 0.96 (0.86–1.12) | 0.173 | ||
T (T2 vs. T1) | 2.23 (1.02–4.89) | 0.007 | 2.01 (1.04–4.79) | 0.013 |
N (N+ vs.N0) | 1.34 (0.89–3.45) | 0.254 | ||
LVI(yes vs. no) | 1.43 (0.67–3.87) | 0.336 | ||
Grade (III vs. I+II) | 1.88 (0.90–4.02) | 0.052 | ||
Molecular subtype | ||||
TN vs. Luminal | 2.69 (1.18–6.16) | 0.001 | 3.01 (1.34–7.12) | 0.001 |
HER2 vs. Luminal | 2.01(1.62–7.34) | 0.012 | 2.15 (1.21–5.53) | 0.008 |
Abbreviation: HR hazard ratio